| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/03/2011 | US7935670 N-(4,6-dimethyl-2-pyridinyl)-L-valyl- N-(1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-4-((6-methoxy-1-isoquinolinyl)carboxy)-L-prolinamide; viricide; synergistic with other active ingredients |
| 05/03/2011 | US7935530 Polyamides with tail structures capable of binding DNA |
| 05/03/2011 | US7935525 Inhibition of ATF2 activity to treat cancer |
| 05/03/2011 | US7935491 Nucleic acid and corresponding protein entitled 24P4C12 useful in treatment and detection of cancer |
| 05/03/2011 | US7935490 Immunodiagnostic assays using reducing agents |
| 05/03/2011 | US7935355 Antigen to stimulate immunology response; inoculating birds against Salmonella; reduce shedding of Escherichia |
| 05/03/2011 | US7935353 Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| 05/03/2011 | US7935350 Ii-key/Her-2/neu hybrid cancer vaccine |
| 05/03/2011 | US7935348 Combination therapy for the treatment of Alzheimer's disease |
| 05/03/2011 | US7935347 DNA molecule corresponding to a nucleotide sequence of a cereal pollen major allergen; therapy of pollen-allergy diseases |
| 05/03/2011 | US7935342 Methods for treating obesity by administering a trkB antagonist |
| 05/03/2011 | US7935339 Inhibition of the CD95 ligand/receptor system for the treatment of neurological disorders and injuries |
| 05/03/2011 | US7935337 Method of therapy for degenerative intervertebral discs |
| 05/03/2011 | US7935336 Highly functional enzyme having α-galactosidase activity |
| 05/03/2011 | US7935332 Presbyopia treatment by lens alteration |
| 05/03/2011 | CA2581001C Kunitz-type recombinant inhibitor |
| 05/03/2011 | CA2518219C Igf-binding protein-derived peptide or small molecule |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2350776C Novel mitogenic regulators |
| 05/03/2011 | CA2347066C Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
| 05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
| 05/03/2011 | CA2328485C Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 05/03/2011 | CA2321700C Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 05/03/2011 | CA2293805C Use of mhc class ii ligands as adjuvant for vaccination and of lag-3 in cancer treatment |
| 05/03/2011 | CA2283680C Calcium phosphopeptide complexes |
| 05/03/2011 | CA2246297C Use of an anti-human tnf-alpha monoclonal antibody in the manufacture of a therapeutic formulation for treating a thrombotic disorder |
| 05/03/2011 | CA2233207C Type cc chemokine-like protein |
| 05/03/2011 | CA2206509C Novel hedgehog-derived polypeptides |
| 05/03/2011 | CA2174961C Desferrioxamine oral delivery system |
| 04/29/2011 | CA2741418A1 Detection and modulation of cytochrome c acetylation |
| 04/28/2011 | WO2011050357A2 Protein arginine deiminase inhibitors as novel therapeutics for rheumatoid arthritis and cancer |
| 04/28/2011 | WO2011050342A2 Rational design of a biocompatible synthetic laminin-111 polymer and uses thereof |
| 04/28/2011 | WO2011050334A1 Compositions and methods for re-programming cells without genetic modification for treatment of obesity and related diseases |
| 04/28/2011 | WO2011050311A1 Use of endostatin peptides for the treatment of fibrosis |
| 04/28/2011 | WO2011050287A1 Replenishment and enrichment of ocular surface lubrication |
| 04/28/2011 | WO2011050270A2 Macrocyclic inhibitors of serine protease enzymes |
| 04/28/2011 | WO2011050178A2 Targeted prdm gene or protein modulation therapeutic agents |
| 04/28/2011 | WO2011050174A1 Peptidic glp-2 agonists |
| 04/28/2011 | WO2011050135A1 Methods and compositions for the prevention and treatment of influenza |
| 04/28/2011 | WO2011050129A1 Microrna-10 antagonists and microrna-10 targets for use in the treatment of a glioma |
| 04/28/2011 | WO2011050098A2 Compositions, methods and uses for inhibition and/or treatment of influenza infection |
| 04/28/2011 | WO2011050052A2 Protein agent for diabetes treatment and beta cell imaging |
| 04/28/2011 | WO2011050008A2 Combination therapy comprising administration of an amylinomimetic and a pyy peptidomimetic for effecting weight loss and for treating obesity and related metabolic conditions and disorders |
| 04/28/2011 | WO2011049937A1 Kinetically efficient substrate for lipoic acid ligase |
| 04/28/2011 | WO2011049914A2 Anti-hiv peptides and methods of use thereof |
| 04/28/2011 | WO2011049787A1 Method for treating alzheimer's disease using pharmacological chaperones to increase the activity of gangliosidases |
| 04/28/2011 | WO2011049776A1 Therapeutically effective preparations of insulin |
| 04/28/2011 | WO2011049713A2 Stabilized glucagon solutions |
| 04/28/2011 | WO2011049289A2 Polypeptide or fused protein thereof inhibiting the extravasation of white blood cells or the growth and/or metastasis of cancer cells |
| 04/28/2011 | WO2011049200A1 Antipruritic agent |
| 04/28/2011 | WO2011048766A1 Carbonic anhydrase i serving as novel antigen to be used for treatment of autoimmune diseases |
| 04/28/2011 | WO2011048602A1 Compounds restoring pancreatic beta cells |
| 04/28/2011 | WO2011048479A2 Compositions that include anthocyanidins and methods of use |
| 04/28/2011 | WO2011048445A1 Inhibitors of guanine exchange factors and their use as anticancer drugs |
| 04/28/2011 | WO2011048443A1 Neuronal exocytosis inhibiting peptides derived from c subunit of v-atpase and cosmetic and pharmaceutical compositions containing said peptides |
| 04/28/2011 | WO2011048387A2 Treatment of pre-term neonates |
| 04/28/2011 | WO2011048248A1 Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof |
| 04/28/2011 | WO2011048029A1 Cyclic peptide synthesis |
| 04/28/2011 | WO2011047926A1 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents |
| 04/28/2011 | WO2011047868A2 Peptides used in the treatment and/or care of the skin, mucous membranes and/or hair and its use in cosmetic or pharmaceutical compositions |
| 04/28/2011 | WO2011047794A2 Medical utility of glycan-binding proteins and glycans |
| 04/28/2011 | WO2011047631A1 Proteins or polypeptides with cd137l function and genes encoding the same and uses thereof |
| 04/28/2011 | WO2011047434A1 A pharmaceutical composition for treating cancer comprising trypsinogen and/or chymotrypsinogen and an active agent selected from a selenium compound, a vanilloid compound and a cytoplasmic glycolysis reduction agent |
| 04/28/2011 | WO2011027060A3 Oxytocin treatment for behavioral characteristics associated with autism and shyness disorder |
| 04/28/2011 | WO2011026122A3 B7-h4 fusion proteins and methods of use thereof |
| 04/28/2011 | WO2011006070A3 Genetic association of polymorphisms in perilipin (plin) gene with resistance to weight loss |
| 04/28/2011 | WO2011005523A3 Galectin-immunoglobulin chimeric molecules |
| 04/28/2011 | WO2010151495A3 Materials and methods for treating and preventing viral infections |
| 04/28/2011 | WO2010138955A3 Methods and compositions for treating neoplasia |
| 04/28/2011 | WO2010136981A3 Meganuclease variants cleaving the genome of a pathogenic non-integrating virus and uses thereof |
| 04/28/2011 | WO2010135736A3 Application and uses of prg4 and therapeutic modulation thereof |
| 04/28/2011 | WO2010129895A3 Cd133 epitopes |
| 04/28/2011 | WO2010096754A8 Compositions and methods to prevent and/or treat cancer with pa -card |
| 04/28/2011 | WO2010032011A8 Anti-fungal therapy |
| 04/28/2011 | WO2009069002A3 Low dose colony stimulating factors to treat amyloidosis |
| 04/28/2011 | WO2009060316A3 Hepatitis b virus-binding polypeptides and methods of use thereof |
| 04/28/2011 | WO2008070943A3 Soluble dimerized or oligomerized endostatin |
| 04/28/2011 | US20110098631 Medical devices for treating urological and uterine conditions |
| 04/28/2011 | US20110098340 Antisense modulation of bcl2-associated x protein expression |
| 04/28/2011 | US20110098237 Methods for inhibiting drug degradation |
| 04/28/2011 | US20110098236 Diamide inhibitors of cytochrome p450 |
| 04/28/2011 | US20110098235 Antineoplastic peptides |
| 04/28/2011 | US20110098234 Breast cancer proteins |
| 04/28/2011 | US20110098233 Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 04/28/2011 | US20110098232 Methods For The Selective Treatment Of Tumors By Calcium-Mediated Induction Of Apoptosis |
| 04/28/2011 | US20110098230 Cosmetic use of annexin ii-type proteins for treating dryness of the skin |
| 04/28/2011 | US20110098229 Compositions and methods for treating dermatological conditions |
| 04/28/2011 | US20110098228 Synthetic analogues of neural regeneration peptides |
| 04/28/2011 | US20110098227 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 04/28/2011 | US20110098226 Small molecular weight TNF receptor multimeric molecule |
| 04/28/2011 | US20110098225 NOVEL PEPTIDES DERIVED FROM NCAM (FGLs) |
| 04/28/2011 | US20110098224 Protein kinase c peptide modulators of angiogenesis |
| 04/28/2011 | US20110098223 Use of the pat nanopeptide in the treatment of autoimmune diseases |
| 04/28/2011 | US20110098222 Glucagon-like-peptide-2 (glp-2) analogues |
| 04/28/2011 | US20110098221 INHIBITORS OF Akt ACTIVITY |
| 04/28/2011 | US20110098220 Methods and kits for preventing hypoglycemia |
| 04/28/2011 | US20110098219 System for Curing Hepatic Cancer with Leptin |
| 04/28/2011 | US20110098218 Modulators of stat3 signalling |
| 04/28/2011 | US20110098217 Compounds exhibiting glucagon antagonist and glp-1 agonist activity |
| 04/28/2011 | US20110098216 Therapeutic uses of colostrinin |